Biopharma innovation trends during COVID-19 and beyond: an evidence from global partnerships and fundraising activities, 2011-2022article Published on 2023-08-142024-09-05 Journal: Globalization and Health [Category] update2024, [키워드] biopharmaceutical industry COVID-19 fundraising Innovation partnership [DOI] 10.1186/s12992-023-00953-6 PMC 바로가기 [Article Type] article
Fusogenicity and neutralization sensitivity of the SARS-CoV-2 Delta sublineage AY.4.2SARS-CoV-2 Delta 하위 계통 AY.4.2의 융합성 및 중화 민감도Article Published on 2022-03-012022-09-11 Journal: EBioMedicine [Category] MERS, SARS, 변종, 진단, 치료기술, [키워드] A222V ACE2 ACE2 binding anti-RBD Anti-RBD antibodies antibody AY.4.2 B.1.617.2 binding changes in characterized COVID-19 Delta delta variant Efficacy exhibited Flash fundraising Fusogenicity Imdevimab impair less Lineage monoclonal monoclonal antibodies Mutation N-terminal domain neutralization Neutralizing antibodies NTD omicron reduced SARS-CoV-2 SARS-CoV-2 lineage sensitivity sequenced sera spikes Spread strain tested the antibody the SARS-CoV-2 vaccinated individual vaccinated individuals Vaccines Viral virus was reduced [DOI] 10.1016/j.ebiom.2022.103934 PMC 바로가기 [Article Type] Article
Evaluating the impact of COVID-19 on rare disease support groupsData Note Published on 2021-05-062022-10-27 Journal: BMC Research Notes [Category] Coronavirus, SARS, [키워드] changed Charity Collaborative group conducted COVID-19 COVID-19 pandemic evaluate Evaluating fundraising group groups help highlight identify Impact increase in media objective Occurrence Online pandemic Patient Population provided Qualitative rare disease significantly Support survey website [DOI] 10.1186/s13104-021-05579-8 PMC 바로가기 [Article Type] Data Note
Continuation versus discontinuation of renin-angiotensin system inhibitors in patients admitted to hospital with COVID-19: a prospective, randomised, open-label trialRandomized Controlled Trial Published on 2021-03-012022-10-05 Journal: The Lancet. Respiratory Medicine [Category] SARS, 임상, [키워드] 1:1 Admission adverse event Affect age Analysis Angiotensin receptor blockers Angiotensin-converting enzyme assigned Biological Block randomisation blood pressure concealed contraindication country COVID creatinine death diabetes died enrolled evaluate female Follow-up fundraising had no Hierarchical hospital hospitalisation individual inhibitor inhibitors intensive care intention-to-treat population International Invasive mechanical ventilation mean body-mass index mechanical ventilation median Multiorgan dysfunction no difference Older Open-label outcome participant Patient Potassium Primary outcome randomised Randomly receiving recommendations Registered renal renin-angiotensin system required secure serum Seven severity of COVID-19 therapy treatment group Trial two groups web-based randomisation system were excluded with COVID-19 [DOI] 10.1016/S2213-2600(20)30558-0 PMC 바로가기 [Article Type] Randomized Controlled Trial
Early Crowdfunding Response to the COVID-19 Pandemic: Cross-sectional StudyOriginal Paper Published on 2021-02-092022-10-30 Journal: Journal of Medical Internet Research [Category] COVID-19, MERS, [키워드] affective Algorithm appear available data Characteristics Cluster Community coronavirus COVID-19 COVID-19 case COVID-19 pandemic cross-sectional crowdfund crowdfunding crowdsource declined disaster disaster relief disease distress early stage Economy examined Facebook fundraise fundraising GoFundMe Government Health Impact incidence increase in lack natural disasters objective organization overlapping pandemic progressed raised reflect response responses Result social media study period subset the United State The United States [DOI] 10.2196/25429 PMC 바로가기 [Article Type] Original Paper